or Try an Advanced Search...

    Recombinant Proteins Stocks List

    Symbol Grade Name % Change
    AMGN B Amgen Inc. -0.71
    ASND D Ascendis Pharma A/S -1.37
    CHRS F Coherus BioSciences, Inc. -2.30
    MODD C Modular Medical, Inc. 1.14
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Medical Devices
    Related Stock Lists: Biotechnology Medicine Diabetes Insulin Peptide Hormones Adalimumab Biopharmaceutical Biosimilar Blood Cells Bone Bone Disease Breakthrough Therapy Breast Cancer Cancer Care Chemotherapy Clinic Clinical Medicine Dialysis Disease Dow Jones Component

    Related ETFs - A few ETFs which own one or more of the above listed Recombinant Proteins stocks.

    Symbol Grade Name Weight
    MEDI D Harbor Health Care ETF 16.82
    BBH B Market Vectors Biotech ETF 16.37
    IBBQ B Invesco Nasdaq Biotechnology ETF 10.1
    IBB B iShares Nasdaq Biotechnology Index Fund 10.07
    BIS F ProShares UltraShort Nasdaq Biotechnology 9.07
    View all Recombinant Proteins ETFs...
    Compare ETFs
    Compare BBH to BIS Compare MEDI to BBH Compare MEDI to IBB

        Recombinant Proteins Stocks Recent News

        Date Stock Title
        May 17 AMGN 4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly
        May 17 AMGN Meet the GLP-1 Drug That Could Be the Biggest Concern for Eli Lilly and Novo Nordisk
        May 17 AMGN Amgen’s IMDELLTRA receives FDA approval for lung cancer treatment
        May 16 AMGN FDA APPROVES IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER
        May 16 AMGN Amgen wins FDA nod for new lung cancer therapy
        May 16 AMGN KRAS inhibitors: The next frontier beckons
        May 15 AMGN AMGEN TO HOST CONFERENCE CALL FOLLOWING ATS 2024
        May 15 ASND FDA Pushes Review Date For Ascendis Pharma's Hormone Disorder Candidate By Three Months
        May 15 ASND FDA Delays Decision on Ascendis' (ASND) Hormone Therapy Filing
        May 14 AMGN Amgen Inc. (AMGN) BofA Securities 2024 Health Care Conference (Transcript)
        May 14 ASND US Equity Markets Close Higher Tuesday as Producer Prices Rise
        May 14 ASND Ascendis Pharma says FDA has delayed TransCon PTH review
        May 14 ASND UPDATE 1-FDA extends review of Ascendis Pharma's hormone disorder therapy
        May 14 ASND Ascendis Pharma Announces Extension of U.S. Food and Drug Administration Review Period for TransCon™ PTH for Adults with Hypoparathyroidism
        May 13 ASND Significant and Sustained Improvements in Renal Function Reported for Adults with Chronic Hypoparathyroidism Treated with TransCon™ PTH (Palopegteriparatide): 2-year Results from Phase 3 PaTHway Trial
        May 13 AMGN The Zacks Analyst Blog Highlights Amgen, Amazon.com, Apple, Boeing and Goldman Sachs
        May 12 AMGN Amgen Is Working On a Wegovy Competitor -- What It Means for Investors
        May 11 CHRS Coherus BioSciences First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
        May 11 AMGN We Wouldn't Be Too Quick To Buy Amgen Inc. (NASDAQ:AMGN) Before It Goes Ex-Dividend
        Related Industries: Biotechnology Drug Manufacturers - Major Medical Devices
        Related Stock Lists: Biotechnology Medicine Diabetes Insulin Peptide Hormones Adalimumab Biopharmaceutical Biosimilar Blood Cells Bone Bone Disease Breakthrough Therapy Breast Cancer Cancer Care Chemotherapy Clinic Clinical Medicine Dialysis Disease Dow Jones Component
        Recombinant Proteins

        Recombinant proteins are proteins that are produced through genetic engineering. They are created by inserting a gene from one organism into another organism, such as a bacteria or yeast, which then produces the desired protein. Recombinant proteins are used in a variety of applications, including medical treatments, research, and industrial processes.

        Browse All Tags